Industry reports
Editor highlights

Biopharmaceutical Industry in Belgium: Market Research Reports, Statistics and Analysis

You might be interested in: biosimilar, protein, bioprocessing, more »

» View Public Reports

5 reports

Bioprocessing in Belgium and France : Innovation and Technology Trends

  • Industry report
  • September 2009
  • 28 pages

... In-class . Publication with inserm unit 553 of the world s first successful independently vald model of a complex human disease in nucleic acids research. Bmsystems operational proofs***. One approach for multiple ...

Company Report: Biopharmaceutical in Belgium for Year 2012

  • Company report
  • November 2012
  • 4 pages

... Virus that infects the lungs and respiratory tract about ablynx ablynx is a biopharmaceutical company engaged in the discovery and development of nanobodies , a novel class of therapeutic proteins ...

Company Report: Biopharmaceutical in The United States and Europe for Year 2012

  • Company report
  • April 2012
  • 2 pages

... About thrombogenics thrombogenics is a biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines. The company s lead product, ocriplasmin, has successfully ...

Wyeth Pharmaceuticals - Company Report for Year 2008

  • Company report
  • January 2008
  • 78 pages

... That are extremely difficult to target with monoclonal antibodies. Post year end, we published important scientific developments in the shape of a novel proprietary half-life extension technology together ...

Search in Biopharmaceutical Industry

» Purchase Premium Reports (From $ 75 - $ 3 800)

10 reports
Biotechnology Market Overview in Belgium

Biotechnology Market Overview in Belgium

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. What's ...

Global Vaccine Market To 2017 - Market Size, Growth, An ...

June 2013 $ 2 488

Biosimilars: World Market Regulatory Update

May 2012 $ 3 800

Ucb S.a. - Swot Analysis

September 2011 $ 175

Ucb Group: Swot Analysis & Company Profile

September 2010 $ 99

Biopharmaceutical In Belgium: Ucb S.a.

April 2010 $ 175

Ucb: Pipeline - Products ? Performance - Potential

January 2010 $ 1 165

Company Financials: Ucb S.a.

January 2010 $ 75

Ablynx Nv Financial Analysis

April 2009 $ 125

Innogenetics Nv Financial Analysis

April 2009 $ 125

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.